Conference Coverage

One in Four Veterans With Stage IV Colon Cancer Receives No Treatment: VAH Versus Other Certified Hospitals in Providing Treatment

Abstract 53: 2016 AVAHO Meeting


 

Background: There are a variety of treatments available for patients with stage IV colon cancer. Chemotherapy is the usual treatment, with greater amounts of surgery being associated with more aggressive hospitals. Income can play a role in the type of treatment a patient receives, or if they even receive treatment at all (Baldwin et al. 2005).

Methods: First course treatment received by stage IV colon cancer patients of Veterans Affair Hospitals (VAH) and all other hospital types were compared using the National Cancer Data Base (NCDB). Patient’ 2012 income and type of treatment provided were examined. Treatment types included chemotherapy, surgery, no treatment, etc. Data from 45 VAH with 2,667 patients and 1,543 non-VA affiliated hospitals with 144,575 patients were utilized. Chi-squared analysis was conducted to calculate statistical significance.

Results: The NCDB reveals noticeable differences between VAH and all other hospitals in percentages of stage IV colon cancer patients receiving treatment. 25.3% of VAH patients received no treatment while 16.9% of patients at all other hospitals received no treatment (P < .05). More VAH patients received solely chemotherapy compared to patients at other hospitals (21.2% vs 15.9%, P < .05). VAH patients had less surgery compared to patients at all other hospitals (47.2% vs 59.4%, P < .05). These effects were present at all income levels.

Implications: VAH patients were more likely to receive no treatment compared to patients at all other hospitals. Furthermore, VAH patients were less likely to receive aggressive surgical care compared to other hospitals. These results imply that VAH patients are more likely to receive no treatment in comparison to other hospitals, as well as less likely to receive aggressive care when treatment is given. Differences in care seen between hospital types were not influenced by income.

Recommended Reading

Breast Cancer Screening Improvement Initiative
AVAHO
Demographic and Clinical Characteristics of Patients With Polycythemia Vera (PV) in the U.S. Veterans Population
AVAHO
Double-Expressor Lymphoma (DEL) in Veterans at DC VAMC
AVAHO
Hematology/Oncology Ordersets: A VA VISN 09 Wide Initiative
AVAHO
Big Data, Precision Oncology, and Virtual Cancer Centers: The VA’s Initiatives Transforming Cancer Care
AVAHO
Treatment Trends in Stage 3 Prostate Cancer in VA vs Academic Centers
AVAHO
Risk Factors Associated With the Development of Adenoma Multiplicity in a Screening Cohort
AVAHO
Clinical Risk Group at Baseline Is Associated With 10 Year Outcomes in a Screening Cohort: A Longitudinal Analysis of the CSP 380 Cohort
AVAHO
CT-Guided Bone Marrow Aspiration and Biopsy Is a Safe and Feasible Option to Decompress Busy Hematology/Oncology Clinics
AVAHO
VA Precision Oncology Program
AVAHO